Chris Keh
Assistant Clinical Professor
Medicine
School of Medicine

Education & Training

Show all (3) Hide

• Fellowship Infectious Diseases University of California, San Francisco
• Residency Internal Medicine University of Chicago
• M.D. College of Medicine University of Illinois, Chicago

Publications (21)

Top publication keywords:
Malaria, FalciparumInterleukin-2AntimalarialsAntitubercular AgentsContact TracingTuberculosis, Multidrug-ResistantAntibodies, ProtozoanPlasmodium falciparumMycobacterium tuberculosisDirectly Observed TherapyAntigens, ProtozoanTuberculosisRifamycinsLatent TuberculosisHIV-1

• A teenage girl with altered mental status and paraparesis.
  Journal of clinical tuberculosis and other mycobacterial diseases 2024 Miyakawa R, Louie J, Keh C, Chen L, Javid B, Ernst JD, Goswami N, Chow FC
• Notes from the Field: Supply Interruptions of First- and Second-Line Oral Drugs to Treat Tuberculosis During the Previous 12 Months - California, January-March, 2023.
  MMWR. Morbidity and mortality weekly report 2024 Nabity SA, Agraz-Lara R, Bravo A, Benjamin R, Fong V, Lam CK, Keh C, Mase S, Flood J
• Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells - United States, 2023.
  MMWR. Morbidity and mortality weekly report 2024 Wortham JM, Haddad MB, Stewart RJ, Annambhotla P, Basavaraju SV, Nabity SA, Griffin IS, McDonald E, Beshearse EM, Grossman MK, Schildknecht KR, Calvet HM, Keh CE, Percak JM, Coloma M, Shaw T, Davidson…
• Latent Tuberculosis Infection Treatment: Still a Long Road Ahead.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023 Louie JK, Keh CE
• Highlighting the characteristics of TB disease in older people.
  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2023 Louie JK, Keh C, Agraz-Lara R, Phillips A, Graves S

Show all (16 more) Hide

• Adverse Events Associated With Treatment for Pan-Susceptible Tuberculosis in San Francisco.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023 Louie JK, Keh C, Agraz-Lara R, Phillips A, Graves S
• Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023 Katrak S, Han E, Readhead A, Fung M, Keh C, Flood J, Barry P
• Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Holzman SB, Perry A, Saleeb P, Pyan A, Keh C, Salcedo K, Narita M, Ahmed A, Miller TL, Pettit AC, Khurana R, Whipple M, Katz D, Largen A, Krueger A, Shah M, Tuberculosis Epidemiologic Studies …
• Systematic review of drug-drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management.
  Pharmacotherapy 2022 MacDougall C, Canonica T, Keh C, P Phan BA, Louie J
• Establishment and Evaluation of a Large Contact-Tracing and Case Investigation Virtual Training Academy.
  American journal of public health 2021 Golston O, Prelip M, Brickley DB, Cass A, Chen L, Dorian A, Gandelman A, Keh C, Maher A, Myrick R, Reid MJA, White K, Willard-Grace R, Shafir S
• Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017-2018).
  American journal of public health 2020 Beeler Asay GR, Lam CK, Stewart B, Mangan JM, Romo L, Marks SM, Morris SB, Gummo CL, Keh CE, Hill AN, Thomas A, Macaraig M, St John K, J Ampie T, Chuck C, Burzynski J
• Two Rapidly Growing Mycobacterial Species Isolated from a Brain Abscess: First Whole-Genome Sequences of Mycobacterium immunogenum and Mycobacterium llatzerense.
  Journal of clinical microbiology 2015 Greninger AL, Langelier C, Cunningham G, Keh C, Melgar M, Chiu CY, Miller S
• Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences.
  PloS one 2015 Eriksson EM, Liegler T, Keh CE, Karlsson AC, Holditch SJ, Pilcher CD, Loeb L, Nixon DF, Hecht FM
• Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection.
  American journal of respiratory and critical care medicine 2014 Kelly JD, Grace Lin SY, Barry PM, Keh C, Higashi J, Metcalfe JZ
• Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda.
  PloS one 2012 Keh CE, Jha AR, Nzarubara B, Lanar DE, Dutta S, Theisen M, Rosenthal PJ, Dorsey G, Nixon DF, Greenhouse B
• Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection.
  PloS one 2012 Eriksson EM, Keh CE, Deeks SG, Martin JN, Hecht FM, Nixon DF
• Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.
  Blood 2011 Eriksson EM, Milush JM, Ho EL, Batista MD, Holditch SJ, Keh CE, Norris PJ, Keating SM, Deeks SG, Hunt PW, Martin JN, Rosenberg MG, Hecht FM, Nixon DF
• A resident-led quality improvement initiative to improve obesity screening.
  American journal of medical quality : the official journal of the American College of Medical Quality 2011 Laiteerapong N, Keh CE, Naylor KB, Yang VL, Vinci LM, Oyler JL, Arora VM
• Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010 Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ
• Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial.
  AIDS (London, England) 2009 Porter BO, Anthony KB, Shen J, Hahn B, Keh CE, Maldarelli F, Blackwelder WC, Lane HC, Kovacs JA, Davey RT, Sereti I
• Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients.
  AIDS (London, England) 2006 Keh CE, Shen JM, Hahn B, Hallahan CW, Rehm CA, Thaker V, Wynne SM, Davey RT, Lane HC, Sereti I